Urinary Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2034
Description
Urinary Catheters Market Summary
This urinary catheters market report offers a comprehensive overview of the global urinary catheters market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Indwelling/Foley Catheters, Intermittent Catheters, and External Catheters), Type (Coated and Uncoated), Design (Single Lumen, Double Lumen, and Triple Lumen), Usage (Male Urinary Catheters and Female Urinary Catheters), Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing urinary catheters market.
Urinary catheters are thin, flexible medical tubes inserted into the bladder through the urethra (or sometimes through a small abdominal incision) to drain urine when a person is unable to urinate naturally. They are commonly used in cases of urinary retention, during and after surgery, in critically ill patients, or for individuals with bladder control problems. Urinary catheters can be temporary (intermittent) or long-term (indwelling), depending on the patient’s medical condition.
The market for urinary catheters is primarily driven by the rising prevalence of urinary disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), urinary retention, and other urological disorders, particularly among the growing elderly population. Increasing numbers of surgical procedures, higher incidence of chronic diseases such as diabetes and spinal cord injuries, and expanding use of catheterization in long-term and home care settings are also fueling demand. Additionally, improvements in catheter materials, infection-prevention technologies, and greater awareness of hygiene and patient care standards are supporting steady market growth.
Get More Insights into the Report @Urinary Catheters Market
What are the latest urinary catheters market dynamics and trends?
The increasing cases of urological disorders such as colorectal cancer, urinary retention, benign prostatic hyperplasia (BPH), and urinary incontinence are significantly boosting the overall market for urinary catheters.
According to the facts and data provided the National Institute of Diabetes and Digestive and Kidney Disease (2024), urologic diseases and conditions had affected individuals of all ages, leading to significant healthcare costs and considerable disability, along with reduced quality of life. Common non-cancerous urologic problems had included urinary tract infections, kidney stones, urinary incontinence, and benign prostatic hyperplasia. Interstitial cystitis/bladder pain syndrome (IC/BPS) had impacted approximately 3.3 million women, while an estimated 1.6 million men had experienced chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), often characterized by pain during bladder filling. National public health surveys conducted over several years had shown that about 54% of women aged 20 years and older reported experiencing urinary incontinence within the previous 12 months, while approximately 15% of men had self-reported the condition.
Thus, the high prevalence of urologic conditions and urinary incontinence reflected in these statistics significantly boosted the urinary catheters market by expanding the overall patient pool requiring bladder management solutions. With more than half of adult women and a notable proportion of men experiencing urinary incontinence, along with millions affected by interstitial cystitis and chronic pelvic pain syndromes, the demand for both short-term and long-term catheterization increased substantially.
According to the recent data and stats provided by DelveInsight Business Research LLP in 2025, globally, the estimated new cases of colorectal cancer was 20,64,416 and the projections further estimated to increase 32,85,215 cases by 2045. Patients undergoing colorectal cancer surgeries such as tumor resection, colectomy, or pelvic surgery often require temporary urinary catheterization to monitor urine output, prevent urinary retention, and manage postoperative bladder function. Additionally, advanced-stage disease or pelvic nerve involvement may lead to bladder dysfunction, increasing the need for intermittent or long-term catheter use.
Furthermore, the presence of key market players are further escalating the overall market of urinary catheters. For instance, in May 2024, Coloplast expanded its Luja™ portfolio with a next-generation intermittent catheter designed specifically for women. This innovative catheter facilitates complete bladder emptying in a single, continuous flow, aiming to help reduce the risk of urinary tract infections (UTIs).
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters during the forecast period from 2026 to 2034.
However, complications such as catheter-associated urinary tract infections (CAUTIs) act as a major restraint on the urinary catheters market because they increase patient morbidity, prolong hospital stays, and raise healthcare costs. Growing concerns about infection risks have led hospitals to adopt stricter catheter usage protocols and reduce unnecessary catheterization, thereby limiting product demand. Additionally, the stringent regulatory approval process for urinary catheters delays product launches and increases development costs for manufacturers. Compliance with rigorous safety, quality, and clinical performance standards requires extensive testing and documentation, which can slow innovation and market entry. Together, infection-related risks and regulatory challenges restrict overall market growth.
Urinary Catheters Market Segment Analysis
Urinary Catheters Market Product Type (Indwelling/Foley Catheters, Intermittent Catheters, and External Catheters), Type (Coated and Uncoated), Design (Single Lumen, Double Lumen, and Triple Lumen), Usage (Male Urinary Catheters and Female Urinary Catheters), Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Urinary Catheters Market Regional Analysis
North America Urinary Catheters Market Trends
North America is poised to secure the largest share of 39% in the global urinary catheters market in 2025, driven by a confluence of factors. The increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, benign prostatic hyperplasia & bladder cancers, among others are boosting the overall market of urinary catheters. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market. Furthermore, increase in product development activites among the key market players are further escalating the overall market of urinary catheters.
Supporting this trend are compelling statistics. According to data from International Agency for Research on Cancer, in 2025, the espected new cases of colorectal cancer cases was 1,94,879 and the projections further estimated that these case would rise upto 2,50,208 by 2045 in North America.
Additionally, accoprding to the data provided by the National Institute of Health (2024), Each year, about 3 in 100,000 women develop acute urinary retention in the United States. Patients undergoing colorectal cancer surgeries often require temporary catheterization to monitor urine output during and after surgery, prevent bladder distension, and manage postoperative urinary retention. Additionally, colorectal tumors or related treatments such as radiation therapy can affect nearby pelvic nerves, leading to urinary dysfunction that necessitates intermittent or indwelling catheter use. Similarly, urinary retention caused by conditions such as benign prostatic hyperplasia (BPH), neurological disorders, or postoperative complications creates sustained demand for catheterization to ensure proper bladder emptying and prevent kidney damage. The growing incidence of colorectal cancer and retention-related disorders, combined with increasing surgical procedures and hospital admissions, is driving higher utilization of urinary catheters, thereby supporting overall market growth.
Furthermore, the market's growth is being propelled by robust innovation and strategic activities among key market players in the region. A notable example is, InnoCare Urologics announced in December 2024 that it received FDA 510(k) clearance for its Egress™ Safety Catheter, designed to prevent injury during accidental or intentional catheter pull-outs. The device is the first to be cleared under a new classification code for “Foley Catheters and Accessories with Additional Safety Features.”
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters in North America during the forecasted period.
Europe Urinary Catheters Market Trends
Europe is driving the growth of the urinary catheters market due to its well-established healthcare infrastructure, rising aging population, and increasing prevalence of urological disorders such as urinary incontinence and benign prostatic hyperplasia (BPH). The region has a high volume of surgical procedures and hospital admissions, which increases the routine use of intermittent and indwelling catheters. Additionally, strong reimbursement policies, early adoption of advanced technologies such as hydrophilic and antimicrobial-coated catheters, and the presence of major medical device manufacturers further support market expansion. Growing awareness about infection prevention and home-based self-catheterization is also contributing to sustained demand across European countries.
According to the data provided by the Urology Foundation Europe (2024), 1 in 2 of the UK population experience a urology condition during their lifetime. Disorders such as urinary retention, benign prostatic hyperplasia (BPH), urinary incontinence, neurogenic bladder, kidney stones, and bladder cancer often impair normal urine flow, requiring intermittent or indwelling catheterization to ensure complete bladder emptying and prevent complications such as infections or kidney damage. The rising global prevalence of these conditions particularly among the aging population has increased hospital visits, surgical interventions, and long-term care needs, all of which drive catheter usage.
Additionally, increasing product development activites among the key market players are further boosting the overall market of urinary catheters. For instance, in July 2024, Convatec, a leading medical products and technologies company, announces the launch of GentleCath Air™ catheter for Women with FeelClean Technology™, in the UK and Italy, following its successful launch in France.
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters in Europe.
Asia-Pacific Urinary Catheters Market Trends
The Asia-Pacific region is emerging as a key growth driver in the urinary catheters market due to its large and rapidly aging population, rising prevalence of urological disorders, and expanding healthcare infrastructure. Increasing cases of urinary incontinence, benign prostatic hyperplasia (BPH), and postoperative urinary retention are driving higher demand for intermittent and indwelling catheters. Additionally, improving access to healthcare services, growing medical tourism, and rising healthcare expenditure in countries such as China, India, and Japan are supporting market expansion. The presence of local manufacturers offering cost-effective products, along with increasing awareness about infection prevention and home-based care, is further accelerating the adoption of urinary catheters across the region.
According to a study published by the National Library of Medicine in 2024, the overall rate of female stress urinary incontinence in China was estimated at 24.5%. The study also reported that, in 2023, stress urinary incontinence was consistently observed in about 10% of individuals in their 20s and 30s, including males in Japan.
Thus, the factors mentioned are expected to boost the overall market of urinary catheters in the Asia-Pacific region during the forecast period.
Who are the major players in the urinary catheters market?
The following are the leading companies in the urinary catheters market. These companies collectively hold the largest market share and dictate industry trends.
The competitive landscape of the urinary catheters market is shaping its growth dynamics through a mix of well-established global players and emerging regional manufacturers, resulting in moderate to high market concentration within key product segments. Large multinational medical device companies such as Becton Dickinson (BD), Convatec, Coloplast, B. Braun Melsungen AG, and Teleflex Incorporated dominate significant share of the market due to their strong brand presence, broad product portfolios, extensive distribution networks, and long-standing relationships with hospitals and healthcare providers worldwide. These players invest heavily in research and development to introduce advanced products such as hydrophilic-coated catheters, antimicrobial catheters, and ergonomic designs that address infection risks and improve patient comfort, reinforcing their competitive positions. Despite this concentration, the market also features numerous regional manufacturers and niche innovators that compete on cost, customization, and local regulatory familiarity especially in emerging markets across Asia-Pacific, Latin America, and the Middle East & Africa. Collaborations, strategic partnerships, mergers & acquisitions, and product line expansions are increasingly common as companies seek to enhance their geographic reach and technological capabilities. Altogether, the competitive landscape is characterized by a blend of concentrated leadership from major global firms and dynamic competition from smaller players, which together drive innovation, pricing strategies, and broader market penetration.
Recent Developmental Activities in the Urinary Catheters Market
Intermittent Catheters
External Catheters
Uncoated
Double Lumen
Triple Lumen
Female Urinary Catheters
Urinary Incontinence
General Surgery
Others
Ambulatory Surgical Centers
Others
AI-Powered Innovations and Applications:
AI-powered innovations in urinary catheters are emerging as transformative solutions aimed at improving infection control, patient monitoring, and clinical decision-making. Advanced “smart catheter” systems are being developed with embedded sensors that continuously monitor urine output, temperature, flow rate, and biochemical markers, transmitting real-time data to hospital monitoring platforms where artificial intelligence algorithms analyze patterns to detect early signs of catheter-associated urinary tract infections (CAUTIs), blockages, or kidney dysfunction. AI models can also predict the risk of urinary retention or sepsis by integrating catheter data with electronic health records, enabling clinicians to intervene earlier and reduce complications. In hospital settings, AI-driven alert systems help determine optimal catheter removal timing, minimizing unnecessary catheter days and lowering infection rates. Additionally, machine learning is being used in product design and material research to develop biofilm-resistant and antimicrobial coatings by simulating bacterial behavior on catheter surfaces. Companies such as Becton Dickinson (BD) and Coloplast are exploring digital health integration and smart monitoring capabilities to complement traditional catheter products. As healthcare increasingly shifts toward connected care and predictive analytics, AI-enabled catheter technologies are expected to enhance patient safety, reduce hospital costs, and create new growth opportunities within the urinary catheters market.
U.S. Tariff Impact Analysis on Urinary Catheters Market:
The U.S. tariff impact on urinary catheters has influenced the market by increasing the cost of imported catheter products and raw materials, which can lead to higher prices for healthcare providers and patients. Since many medical devices including catheters and related supplies are manufactured overseas, particularly in Asia and Europe, tariffs imposed on imports raise production costs for companies that rely on global supply chains. This can reduce profit margins for manufacturers and distributors or shift costs onto healthcare systems. In some cases, tariff-related cost pressures have encouraged manufacturers to localize production, restructure supply chains, or source materials domestically to mitigate import duties. Overall, U.S. tariffs have created a dynamic where cost management and supply chain strategy become key competitive factors in the urinary catheters market.
How This Analysis Helps Clients
1. What is the growth rate of the urinary catheters market?
- The global urinary catheters market is expected to increase from USD 4,464.41 million in 2025 to USD 7,747.60 million by 2034, reflecting strong and sustained growth.
- The global urinary catheters market is growing at a CAGR of 6.36% during the forecast period from 2026 to 2034.
- The market for urinary catheters is primarily driven by the rising prevalence of urinary disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), urinary retention, and other urological disorders, particularly among the growing elderly population. Increasing numbers of surgical procedures, higher incidence of chronic diseases such as diabetes and spinal cord injuries, and expanding use of catheterization in long-term and home care settings are also fueling demand. Additionally, improvements in catheter materials, infection-prevention technologies, and greater awareness of hygiene and patient care standards are supporting steady market growth.
- The leading companies operating in the urinary catheters market include B. Braun Melsungen AG, Hangzhou Formed Medical Devices Co., Ltd., Boston Scientific Corporation, Cook, ConvaTec Inc., Becton, Dickinson, and Company., Teleflex Incorporated, Urocare Products, Inc., BACTIGUARD AB, Hollister Incorporated, Cardinal Health, Rocamed., Amecath, Go Medical Industries Pty Ltd., CURE MEDICAL, LLC, QMD™, Amsino International, Inc., J and M Urinary Catheters LLC., CompactCath, Ribbel International Limited, and others.
- North America is expected to dominate the urinary catheters market because of the increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, Benign Prostatic Hyperplasia & Bladder Cancers, among others. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market. Furthermore, increase in product development activites among the key market players are further escalating the overall market of urinary catheters.
- In the product type segment of the urinary catheters market, the intermittent catheters category is estimated to account for the largest market share in 2025.
- Increasing cases of urological disorders leading to a surge in urinary catheters: Increasing cases of urological disorders such as urinary retention, benign prostatic hyperplasia (BPH), urinary incontinence, kidney stones, bladder obstruction, and neurogenic bladder conditions are significantly driving the demand for urinary catheters. As these conditions impair normal urine flow or bladder control, catheterization becomes essential for effective bladder drainage, monitoring urine output, and preventing complications such as infections or kidney damage.
- The growing number of surgical procedures and hospital admissions escalating the market of urinary catheters: The growing number of surgical procedures and rising hospital admissions are significantly escalating the market for urinary catheters because catheterization is a routine and essential part of perioperative care. During major surgeries such as abdominal, pelvic, orthopedic, cardiovascular, and urological procedures urinary catheters are used to monitor urine output, maintain bladder decompression, and prevent urinary retention. In intensive care units (ICUs) and emergency settings, critically ill patients often require continuous urine output monitoring, further increasing catheter utilization. As global surgical volumes rise due to an aging population, increasing chronic diseases, and expanding healthcare infrastructure, the demand for both short-term indwelling and intermittent urinary catheters continues to grow, thereby driving overall market expansion.
- Increase in product development activites among the key market players: Companies are investing in innovations such as antimicrobial and hydrophilic coatings to reduce catheter-associated urinary tract infections (CAUTIs), silicone-based materials for improved biocompatibility, and pre-lubricated intermittent catheters for enhanced comfort and ease of use. Additionally, the development of compact, discreet designs for self-catheterization supports the growing home healthcare segment. These technological improvements not only enhance clinical outcomes and patient satisfaction but also encourage premium product adoption, thereby driving revenue growth and expanding the overall urinary catheters market.
This urinary catheters market report offers a comprehensive overview of the global urinary catheters market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Indwelling/Foley Catheters, Intermittent Catheters, and External Catheters), Type (Coated and Uncoated), Design (Single Lumen, Double Lumen, and Triple Lumen), Usage (Male Urinary Catheters and Female Urinary Catheters), Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing urinary catheters market.
Urinary catheters are thin, flexible medical tubes inserted into the bladder through the urethra (or sometimes through a small abdominal incision) to drain urine when a person is unable to urinate naturally. They are commonly used in cases of urinary retention, during and after surgery, in critically ill patients, or for individuals with bladder control problems. Urinary catheters can be temporary (intermittent) or long-term (indwelling), depending on the patient’s medical condition.
The market for urinary catheters is primarily driven by the rising prevalence of urinary disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), urinary retention, and other urological disorders, particularly among the growing elderly population. Increasing numbers of surgical procedures, higher incidence of chronic diseases such as diabetes and spinal cord injuries, and expanding use of catheterization in long-term and home care settings are also fueling demand. Additionally, improvements in catheter materials, infection-prevention technologies, and greater awareness of hygiene and patient care standards are supporting steady market growth.
Get More Insights into the Report @Urinary Catheters Market
What are the latest urinary catheters market dynamics and trends?
The increasing cases of urological disorders such as colorectal cancer, urinary retention, benign prostatic hyperplasia (BPH), and urinary incontinence are significantly boosting the overall market for urinary catheters.
According to the facts and data provided the National Institute of Diabetes and Digestive and Kidney Disease (2024), urologic diseases and conditions had affected individuals of all ages, leading to significant healthcare costs and considerable disability, along with reduced quality of life. Common non-cancerous urologic problems had included urinary tract infections, kidney stones, urinary incontinence, and benign prostatic hyperplasia. Interstitial cystitis/bladder pain syndrome (IC/BPS) had impacted approximately 3.3 million women, while an estimated 1.6 million men had experienced chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), often characterized by pain during bladder filling. National public health surveys conducted over several years had shown that about 54% of women aged 20 years and older reported experiencing urinary incontinence within the previous 12 months, while approximately 15% of men had self-reported the condition.
Thus, the high prevalence of urologic conditions and urinary incontinence reflected in these statistics significantly boosted the urinary catheters market by expanding the overall patient pool requiring bladder management solutions. With more than half of adult women and a notable proportion of men experiencing urinary incontinence, along with millions affected by interstitial cystitis and chronic pelvic pain syndromes, the demand for both short-term and long-term catheterization increased substantially.
According to the recent data and stats provided by DelveInsight Business Research LLP in 2025, globally, the estimated new cases of colorectal cancer was 20,64,416 and the projections further estimated to increase 32,85,215 cases by 2045. Patients undergoing colorectal cancer surgeries such as tumor resection, colectomy, or pelvic surgery often require temporary urinary catheterization to monitor urine output, prevent urinary retention, and manage postoperative bladder function. Additionally, advanced-stage disease or pelvic nerve involvement may lead to bladder dysfunction, increasing the need for intermittent or long-term catheter use.
Furthermore, the presence of key market players are further escalating the overall market of urinary catheters. For instance, in May 2024, Coloplast expanded its Luja™ portfolio with a next-generation intermittent catheter designed specifically for women. This innovative catheter facilitates complete bladder emptying in a single, continuous flow, aiming to help reduce the risk of urinary tract infections (UTIs).
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters during the forecast period from 2026 to 2034.
However, complications such as catheter-associated urinary tract infections (CAUTIs) act as a major restraint on the urinary catheters market because they increase patient morbidity, prolong hospital stays, and raise healthcare costs. Growing concerns about infection risks have led hospitals to adopt stricter catheter usage protocols and reduce unnecessary catheterization, thereby limiting product demand. Additionally, the stringent regulatory approval process for urinary catheters delays product launches and increases development costs for manufacturers. Compliance with rigorous safety, quality, and clinical performance standards requires extensive testing and documentation, which can slow innovation and market entry. Together, infection-related risks and regulatory challenges restrict overall market growth.
Urinary Catheters Market Segment Analysis
Urinary Catheters Market Product Type (Indwelling/Foley Catheters, Intermittent Catheters, and External Catheters), Type (Coated and Uncoated), Design (Single Lumen, Double Lumen, and Triple Lumen), Usage (Male Urinary Catheters and Female Urinary Catheters), Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Urinary Catheters Market Regional Analysis
North America Urinary Catheters Market Trends
North America is poised to secure the largest share of 39% in the global urinary catheters market in 2025, driven by a confluence of factors. The increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, benign prostatic hyperplasia & bladder cancers, among others are boosting the overall market of urinary catheters. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market. Furthermore, increase in product development activites among the key market players are further escalating the overall market of urinary catheters.
Supporting this trend are compelling statistics. According to data from International Agency for Research on Cancer, in 2025, the espected new cases of colorectal cancer cases was 1,94,879 and the projections further estimated that these case would rise upto 2,50,208 by 2045 in North America.
Additionally, accoprding to the data provided by the National Institute of Health (2024), Each year, about 3 in 100,000 women develop acute urinary retention in the United States. Patients undergoing colorectal cancer surgeries often require temporary catheterization to monitor urine output during and after surgery, prevent bladder distension, and manage postoperative urinary retention. Additionally, colorectal tumors or related treatments such as radiation therapy can affect nearby pelvic nerves, leading to urinary dysfunction that necessitates intermittent or indwelling catheter use. Similarly, urinary retention caused by conditions such as benign prostatic hyperplasia (BPH), neurological disorders, or postoperative complications creates sustained demand for catheterization to ensure proper bladder emptying and prevent kidney damage. The growing incidence of colorectal cancer and retention-related disorders, combined with increasing surgical procedures and hospital admissions, is driving higher utilization of urinary catheters, thereby supporting overall market growth.
Furthermore, the market's growth is being propelled by robust innovation and strategic activities among key market players in the region. A notable example is, InnoCare Urologics announced in December 2024 that it received FDA 510(k) clearance for its Egress™ Safety Catheter, designed to prevent injury during accidental or intentional catheter pull-outs. The device is the first to be cleared under a new classification code for “Foley Catheters and Accessories with Additional Safety Features.”
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters in North America during the forecasted period.
Europe Urinary Catheters Market Trends
Europe is driving the growth of the urinary catheters market due to its well-established healthcare infrastructure, rising aging population, and increasing prevalence of urological disorders such as urinary incontinence and benign prostatic hyperplasia (BPH). The region has a high volume of surgical procedures and hospital admissions, which increases the routine use of intermittent and indwelling catheters. Additionally, strong reimbursement policies, early adoption of advanced technologies such as hydrophilic and antimicrobial-coated catheters, and the presence of major medical device manufacturers further support market expansion. Growing awareness about infection prevention and home-based self-catheterization is also contributing to sustained demand across European countries.
According to the data provided by the Urology Foundation Europe (2024), 1 in 2 of the UK population experience a urology condition during their lifetime. Disorders such as urinary retention, benign prostatic hyperplasia (BPH), urinary incontinence, neurogenic bladder, kidney stones, and bladder cancer often impair normal urine flow, requiring intermittent or indwelling catheterization to ensure complete bladder emptying and prevent complications such as infections or kidney damage. The rising global prevalence of these conditions particularly among the aging population has increased hospital visits, surgical interventions, and long-term care needs, all of which drive catheter usage.
Additionally, increasing product development activites among the key market players are further boosting the overall market of urinary catheters. For instance, in July 2024, Convatec, a leading medical products and technologies company, announces the launch of GentleCath Air™ catheter for Women with FeelClean Technology™, in the UK and Italy, following its successful launch in France.
Thus, the factors mentioned above are expected to boost the overall market of urinary catheters in Europe.
Asia-Pacific Urinary Catheters Market Trends
The Asia-Pacific region is emerging as a key growth driver in the urinary catheters market due to its large and rapidly aging population, rising prevalence of urological disorders, and expanding healthcare infrastructure. Increasing cases of urinary incontinence, benign prostatic hyperplasia (BPH), and postoperative urinary retention are driving higher demand for intermittent and indwelling catheters. Additionally, improving access to healthcare services, growing medical tourism, and rising healthcare expenditure in countries such as China, India, and Japan are supporting market expansion. The presence of local manufacturers offering cost-effective products, along with increasing awareness about infection prevention and home-based care, is further accelerating the adoption of urinary catheters across the region.
According to a study published by the National Library of Medicine in 2024, the overall rate of female stress urinary incontinence in China was estimated at 24.5%. The study also reported that, in 2023, stress urinary incontinence was consistently observed in about 10% of individuals in their 20s and 30s, including males in Japan.
Thus, the factors mentioned are expected to boost the overall market of urinary catheters in the Asia-Pacific region during the forecast period.
Who are the major players in the urinary catheters market?
The following are the leading companies in the urinary catheters market. These companies collectively hold the largest market share and dictate industry trends.
- B. Braun Melsungen AG
- Hangzhou Formed Medical Devices Co., Ltd.
- Boston Scientific Corporation
- Cook
- ConvaTec Inc.
- Becton, Dickinson, and Company.
- Teleflex Incorporated
- Urocare Products, Inc.
- BACTIGUARD AB
- Hollister Incorporated
- Cardinal Health
- Rocamed.
- Amecath
- Go Medical Industries Pty Ltd.
- CURE MEDICAL, LLC
- QMD™
- Amsino International, Inc.
- J and M Urinary Catheters LLC.
- CompactCath
- Ribbel International Limited
- Others
The competitive landscape of the urinary catheters market is shaping its growth dynamics through a mix of well-established global players and emerging regional manufacturers, resulting in moderate to high market concentration within key product segments. Large multinational medical device companies such as Becton Dickinson (BD), Convatec, Coloplast, B. Braun Melsungen AG, and Teleflex Incorporated dominate significant share of the market due to their strong brand presence, broad product portfolios, extensive distribution networks, and long-standing relationships with hospitals and healthcare providers worldwide. These players invest heavily in research and development to introduce advanced products such as hydrophilic-coated catheters, antimicrobial catheters, and ergonomic designs that address infection risks and improve patient comfort, reinforcing their competitive positions. Despite this concentration, the market also features numerous regional manufacturers and niche innovators that compete on cost, customization, and local regulatory familiarity especially in emerging markets across Asia-Pacific, Latin America, and the Middle East & Africa. Collaborations, strategic partnerships, mergers & acquisitions, and product line expansions are increasingly common as companies seek to enhance their geographic reach and technological capabilities. Altogether, the competitive landscape is characterized by a blend of concentrated leadership from major global firms and dynamic competition from smaller players, which together drive innovation, pricing strategies, and broader market penetration.
Recent Developmental Activities in the Urinary Catheters Market
- In May 2025, BEVER Medical highlighted emerging trends in intermittent catheter design, emphasizing the increasing adoption of hydrophilic-coated catheters made with DEHP-free PVC and pre-lubricated, compact designs tailored for home use, hospital settings, and military/emergency deployment.
- Urinary Catheters by Product Type Exposure
Intermittent Catheters
External Catheters
- Urinary Catheters Type Exposure
Uncoated
- Urinary Catheters Design Exposure
Double Lumen
Triple Lumen
- Urinary Catheters Usage Exposure
Female Urinary Catheters
- Urinary Catheters Application Exposure
Urinary Incontinence
General Surgery
Others
- Urinary Catheters End-Users Exposure
Ambulatory Surgical Centers
Others
- Urinary Catheters Geography Exposure
- United States Urinary Catheters Market
- Canada Urinary Catheters Market
- Mexico Urinary Catheters Market
- United Kingdom Urinary Catheters Market
- Germany Urinary Catheters Market
- France Urinary Catheters Market
- Italy Urinary Catheters Market
- Spain Urinary Catheters Market
- Rest of Europe Urinary Catheters Market
- China Urinary Catheters Market
- Japan Urinary Catheters Market
- India Urinary Catheters Market
- Australia Urinary Catheters Market
- South Korea Urinary Catheters Market
- Rest of Asia-Pacific Urinary Catheters Market
- South America Urinary Catheters Market
- Middle East Urinary Catheters Market
- Africa Urinary Catheters Market
AI-Powered Innovations and Applications:
AI-powered innovations in urinary catheters are emerging as transformative solutions aimed at improving infection control, patient monitoring, and clinical decision-making. Advanced “smart catheter” systems are being developed with embedded sensors that continuously monitor urine output, temperature, flow rate, and biochemical markers, transmitting real-time data to hospital monitoring platforms where artificial intelligence algorithms analyze patterns to detect early signs of catheter-associated urinary tract infections (CAUTIs), blockages, or kidney dysfunction. AI models can also predict the risk of urinary retention or sepsis by integrating catheter data with electronic health records, enabling clinicians to intervene earlier and reduce complications. In hospital settings, AI-driven alert systems help determine optimal catheter removal timing, minimizing unnecessary catheter days and lowering infection rates. Additionally, machine learning is being used in product design and material research to develop biofilm-resistant and antimicrobial coatings by simulating bacterial behavior on catheter surfaces. Companies such as Becton Dickinson (BD) and Coloplast are exploring digital health integration and smart monitoring capabilities to complement traditional catheter products. As healthcare increasingly shifts toward connected care and predictive analytics, AI-enabled catheter technologies are expected to enhance patient safety, reduce hospital costs, and create new growth opportunities within the urinary catheters market.
U.S. Tariff Impact Analysis on Urinary Catheters Market:
The U.S. tariff impact on urinary catheters has influenced the market by increasing the cost of imported catheter products and raw materials, which can lead to higher prices for healthcare providers and patients. Since many medical devices including catheters and related supplies are manufactured overseas, particularly in Asia and Europe, tariffs imposed on imports raise production costs for companies that rely on global supply chains. This can reduce profit margins for manufacturers and distributors or shift costs onto healthcare systems. In some cases, tariff-related cost pressures have encouraged manufacturers to localize production, restructure supply chains, or source materials domestically to mitigate import duties. Overall, U.S. tariffs have created a dynamic where cost management and supply chain strategy become key competitive factors in the urinary catheters market.
How This Analysis Helps Clients
- Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
- Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
- Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
- Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
- Market size analysis for the current urinary catheters market size (2025), and market forecast for 8 years (2026 to 2034)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the Urinary Catheters market.
- Various opportunities available for the other competitors in the urinary catheters market space.
- What are the top-performing segments in 2025? How these segments will perform in 2034?
- Which are the top-performing regions and countries in the current urinary catheters market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the urinary catheters market growth in the future?
1. What is the growth rate of the urinary catheters market?
- The urinary catheters market is estimated to grow at a CAGR of 6.36% during the forecast period from 2026 to 2034.
- The global urinary catheters market is expected to increase from USD 4,464.41 million in 2025 to USD 7,747.60 million by 2034, reflecting strong and sustained growth.
- North America is poised to secure the largest share of XX% in the global urinary catheters market in 2025, driven by a confluence of factors. The increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, benign prostatic hyperplasia & bladder cancers, among others are boosting the overall market of urinary catheters. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market. Furthermore, increase in product development activites among the key market players are further escalating the overall market of urinary catheters.
- The market for urinary catheters is primarily driven by the rising prevalence of urinary disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), urinary retention, and other urological disorders, particularly among the growing elderly population. Increasing numbers of surgical procedures, higher incidence of chronic diseases such as diabetes and spinal cord injuries, and expanding use of catheterization in long-term and home care settings are also fueling demand. Additionally, improvements in catheter materials, infection-prevention technologies, and greater awareness of hygiene and patient care standards are supporting steady market growth.
- Some of the key market players operating in the urinary catheters market include B. Braun Melsungen AG, Hangzhou Formed Medical Devices Co., Ltd., Boston Scientific Corporation, Cook, ConvaTec Inc., Becton, Dickinson, and Company., Teleflex Incorporated, Urocare Products, Inc., BACTIGUARD AB, Hollister Incorporated, Cardinal Health, Rocamed., Amecath, Go Medical Industries Pty Ltd., CURE MEDICAL, LLC, QMD™, Amsino International, Inc., J and M Urinary Catheters LLC., CompactCath, Ribbel International Limited, and others.
Table of Contents
150 Pages
- 1. Urinary Catheters Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Urinary Catheters Market Executive Summary
- 2.1 Market at Glance
- 3. Urinary Catheters Market Key Factors Analysis
- 3.1 Urinary Catheters Market Drivers
- 3.1.1 Increasing cases of urological disorders leading to a surge in urinary catheters
- 3.1.2 The growing number of surgical procedures and hospital admissions escalating the market of urinary catheters
- 3.1.3 Increase in product development activities among the key market players
- 3.2 Urinary Catheters Market Restraints and Challenges
- 3.2.1 Complications such as catheter-associated urinary tract infection
- 3.2.2 Stringent regulatory process for product approval
- 3.3 Urinary Catheters Market Opportunity
- 3.3.1 Increase in technological advancements such as AI-enabled smart catheters, infection-resistant coatings, biofilm-resistant materials
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Urinary Catheters Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Urinary Catheters Market Assessment
- 7.1 By Product Type
- 7.1.1 Indwelling/Foley Catheters
- 7.1.2 Intermittent Catheters
- 7.1.3 External Catheters
- 7.2 By Type
- 7.2.1 Coated
- 7.2.2 Uncoated
- 7.3 By Design
- 7.3.1 Single Lumen
- 7.3.2 Double Lumen
- 7.3.3 Triple Lumen
- 7.4 By Usage
- 7.4.1 Male Urinary Catheters
- 7.4.2 Female Urinary Catheters
- 7.5 By Appliaction
- 7.5.1 Benign Prostatic Hyperplasi
- 7.5.2 Urinary Incontinence
- 7.5.3 General Surgery
- 7.5.4 Others
- 7.6 By End-Users
- 7.6.1 Hospitals
- 7.6.2 Ambulatory Surgical Centers
- 7.6.3 Others
- 7.7 By Geography
- 7.7.1 North America
- 7.7.1.1 United States Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.1.2 Canada Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.1.3 Mexico Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2 Europe
- 7.7.2.1 France Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2.2 Germany Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2.3 United Kingdom Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2.4 Italy Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2.5 Spain Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.2.6 Rest of Europe Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3 Asia-Pacific
- 7.7.3.1 China Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3.2 Japan Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3.3 India Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3.4 Australia Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3.5 South Korea Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.3.6 Rest of Asia-Pacific Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.4 Rest of the World (RoW)
- 7.7.4.1 Middle East Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.4.2 Africa Urinary Catheters Market Size in USD million (2023-2034)
- 7.7.4.3 South America Urinary Catheters Market Size In USD Million (2023-2034)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Urinary Catheters Market Company and Product Profiles
- 10.1 B. Braun Melsungen AG
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Hangzhou Formed Medical Devices Co., Ltd.
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Cook
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 ConvaTec Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Becton, Dickinson, and Company.
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Teleflex Incorporated
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 Urocare Products, Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 BACTIGUARD AB
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 Hollister Incorporated
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Cardinal Health
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Rocamed.
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 Amecath
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Go Medical Industries Pty Ltd.
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 CURE MEDICAL, LLC
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 QMD™
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 Amsino International, Inc.
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 J and M Urinary Catheters LLC.
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 CompactCath
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 Ribbel International Limited
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
